Fagron NV ARSUF:Grey Market

RT Quote | Exchange | USD
Last | 02/17/21 EST
24.44UNCH (UNCH)
52 week range
12.75 - 25.59

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close24.44
  • 52 Week High25.59
  • 52 Week High Date10/01/20
  • 52 Week Low12.75
  • 52 Week Low Date03/30/20
  • Market Cap1,780.48M
  • Shares Out72.08M
  • 10 Day Average Volume9,469
  • Dividend0.09
  • Dividend Yield0.36%
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)1.01
  • P/E (TTM)24.11
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Fagron NV News

There is no recent news for this security.

Latest ARSUF News From Our Partners

QUOTE FINDER

Profile

MORE
Fagron NV, formerly Arseus NV, is a Belgium-based company that is active in the healthcare sector. It operates as a research and development (R&D) scientific pharmaceutical compounding supplier and operates through four segments: The Fagron Specialty Pharma Services segment comprises personalized medication that is produced in the Company's compounding facilities; the Fagron Trademarks segment encompasses concepts and formulations developed by the Company's research and...
Koen Hoffman
Chairman
Rafael Padilla
Chief Executive Officer
Karin de Jong
Chief Financial Officer
Address
Venecoweg 20A
Nazareth
9810
Belgium